Crossmark

How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?

Published Online: 2026-04-09

Published Print: 2026-06

Authors

Li, Hongru

Zhang, Jiayue

Shen, Linxing

Luo, Pei
License Information

Text and Data Mining valid from 2026-04-09

Version of Record valid from 2026-04-09
More Information

Article History

Received: 22 December 2025

Accepted: 8 March 2026

First Online: 9 April 2026

Declarations

:

: The authors who participate in this comment have no conflicts of interest to declare.

: Not applicable.

: Not applicable.

Document is current